Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
批准号:
RGPIN-2017-06461
负责人:
Rudd, Christopher
金额:
$2.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
中文摘要
我们NSERC研究计划的目标是了解控制下游功能的抗原受体近端信号事件,如钙动员和接头和激酶的聚集。介导t细胞活化的初始事件是由近端酪氨酸激酶(如p56lck和ZAP-70)及其磷酸化的接头蛋白介导的。接子反过来介导细胞中整合信号所需的复合物的形成。其中一个关键的接头蛋白是SLP-76(含有白细胞蛋白76kDa的SH2结构域),它在促进T细胞的活化和发育中起着积极的作用。SLP-76含有一个无菌α基序(SAM)结构域,我们之前发现该结构域介导SLP-76二聚体和低聚物的形成。我们还发现,酪氨酸激酶ACK1 Cdc42(细胞分裂周期42)激活的酪氨酸激酶1 (ACK1或Tnk2)与SLP-76结合,而SLP-76 SAM结构域的缺失破坏了这种结合。TCR诱导磷脂酶C (plc γ - 1)活化和钙动员的经典模型涉及另一种激酶ZAP-70及其磷酸化和白细胞介素2诱导的t细胞激酶(ITK)向SLP-76的募集。我们发现ACK1表达诱导SLP-76磷酸化和钙内流,因此,SLP-76-ACK1模块可以代表激活t细胞中钙动员和f -肌动蛋白组装的第二个模块途径。为了验证这一模型,我们提出:目的1:检验ACK1与SLP-76的结合是否需要SAM结构域介导的寡聚化。我们发现ACK1可以磷酸化SLP-76上的这些关键酪氨酸,并通过其SAM结构域与SLP-76结合。本文介绍了t细胞中SLP-76功能调控的新机制。******我们建议:目标1:直接评估SLP-76 SAM结构域与ACK1 SAM结构域的结合,确定SLP-76 SAM结构域中介导ACK1 SAM结合的特定位点,评估这种相互作用是否激活ACK1并诱导选择性SLP-76酪氨酸残基(y113,128,145),并确定TCR与辅助受体信号的性质,这些信号有利于SLP-76-ACK1结合。目的2:在SLP-76缺陷的J14 Jurkat t细胞和原代t细胞中,利用小抑制剂sirna敲除ACK1或表达不能与ACK1结合的SLP-76突变体,观察其是否降低plc - γ1和ITK磷酸化、催化活性和钙内流,并与SLP-76相关的NCK-WIP-WASP协同诱导肌动蛋白聚合。目的3:评估ACK-1是否与酪氨酸蛋白激酶ZAP-70磷酸化SLP-76竞争或互补。我们将比较ACK-1和ZAP-70在介导SLP-76和plc - γ -1磷酸化以及细胞内钙动员方面的相对能力。
英文摘要
The goal of our NSERC research program is to understand the antigen-receptor proximal signaling events that control downstream functions such as calcium mobilization and the aggregation of adaptors and kinases. The initial events that mediate activation of T-cells are mediated by proximal tyrosine kinases such as p56lck and ZAP-70 and their phosphorylation of adaptor proteins. Adaptors in turn mediate the formation of complexes needed to integrate signalling in cells. One key adaptor protein is SLP-76 (SH2 domain containing leukocyte protein of 76kDa) which plays a positive role in promoting T cell activation and development. SLP-76 contains a sterile- alpha motif (SAM) domain that we previously showed mediates SLP-76 dimer and oligomer formation. We have also shown that the tyrosine kinase ACK1 Cdc42 (cell division cycle 42)-activated tyrosine kinase 1 (ACK1 or Tnk2) binds to SLP-76 and that the loss of the SLP-76 SAM domain disrupts binding. The classic model for TCR induction of phospholipase C (PLCγ1) activation and calcium mobilization involves another kinase ZAP-70 and its phosphorylation and its recruitment of interleukin-2-inducible T-cell kinase (ITK) to SLP-76. We found that ACK1 expression induced SLP-76 phosphorylation and calcium influx, and as such, the SLP-76-ACK1 module could represent a second modular pathway for the activation calcium mobilization and F-actin assembly in T-cells. To test this model, we propose: Aim 1: to examine whether the SAM domain mediated oligomerization is needed for the binding of ACK1 to SLP-76. We have discovered that ACK1 can phosphorylate SLP-76 on these key tyrosines and binds to SLP-76 via its SAM domain. This introduces are novel mechanism to regulate SLP-76 function in T-cells. ******We propose to: Aim 1: to assess directly SLP-76 SAM domain binding to the ACK1 SAM domain, define specific sites in the SLP-76 SAM domain that mediates ACK1 SAM binding, assess whether the interaction activates ACK1 and induces selective SLP-76 tyrosine residues (Y113,128, 145) and define the nature of TCR vs. co-receptor signals that favours SLP-76-ACK1 binding. Aim 2: to use small inhibitor siRNAs to knock-down ACK1 or express SLP-76 mutants unable to bind to ACK1 in SLP-76 deficient J14 Jurkat T-cells and primary T-cells to see whether it reduces PLCγ1 and ITK phosphorylation, catalytic activity and calcium influx and cooperates with SLP-76 associated NCK-WIP-WASP to induce actin polymerization. Aim 3: to assess whether ACK-1 competes with or complements phosphorylation of SLP-76 by the protein-tyrosine kinase ZAP-70. ACK-1 and ZAP-70 will be compared for their relative abilities to mediate SLP-76 and PLCγ1 phosphorylation as well as the mobilization of intracellular calcium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.95万
-
财政年份:2021
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2020
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2019
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2017
-
负责人:Rudd, Christopher
-
依托单位:
国内基金
海外基金
登录
查看更多内容
选择性ACK1抑制剂的设计、合成及抗肿瘤活性研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭靖
-
依托单位:
ACK1/TNK2在嗜神经肠道病毒感染扩散中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:蒋红兵
-
依托单位:
Lnc-MPLKIP-6竞争性抑制SIAH1介导的ACK1泛素化调控肺腺癌EGFR-TKI耐药的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:马建群
-
依托单位:
Ack1介导新型EGFR三代抑制剂120067耐药机制研究
-
批准号:81903638
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:张弢
-
依托单位:
DDR2在炎症信号通路IL-6/STAT3/ACK1介导肝癌发生中的作用及机制
-
批准号:81760496
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:谢斌辉
-
依托单位:
非受体酪氨酸激酶ACK1通过调控YAP蛋白活性促进膀胱癌生长的机制研究
-
批准号:81602223
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:胡连鑫
-
依托单位:
ACK1介导的受体酪氨酸激酶信号在肿瘤发生发展中的作用
-
批准号:81472558
-
项目类别:面上项目
-
资助金额:74.0万元
-
批准年份:2014
-
负责人:杨万年
-
依托单位:
Ack1介导的PDGFR-AKT信号在神经胶质瘤发生发展中的功能及相关机制研究
-
批准号:81372705
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:葛建伟
-
依托单位:
ACK1作为新的心肌肥厚和心力衰竭治疗靶点的实验研究
-
批准号:30900590
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2009
-
负责人:陈莉
-
依托单位: